Plasma Membrane Proteins: Dysferlin, Caveolin, PTRF/Cavin, Integrin α7, and Integrin α9

Straub,; De, Waele; Barresi, Rita

doi:10.1002/9781118635469.ch10

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

2016

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 EMG findings include nonspecific "myopathic" changes. 11 EMG findings include nonspecific "myopathic" changes.…”

Section: Discussionmentioning

confidence: 99%

Neuromuscular Pathology Case

Nguyen¹,

Lacomis

2014

Journal of Clinical Neuromuscular Disease

View full text Add to dashboard Cite

“…11 EMG findings include nonspecific "myopathic" changes. 11 EMG findings include nonspecific "myopathic" changes.…”

Section: Discussionmentioning

confidence: 99%

Neuromuscular Pathology Case

Nguyen¹,

Lacomis

2014

Journal of Clinical Neuromuscular Disease

View full text Add to dashboard Cite

Preand posttranscriptional genetic information modification in muscular dystrophy treatment

Yakovlev,

Deev,

Solovyeva

et al. 2016

Genes & Cells

View full text Add to dashboard Cite

Nowadays, a whole range of genetherapeutic methods is being used to restore a lost protein function due to mutation, a big number of preclinical and clinical studies of potential drugs that may allow to implement an etiotropic approach is being performed. 0ne of the most prevalent and socially significant groups of genetic pathologies is muscular dystrophy, including such diseases as Duchenne muscular dystrophy and dysfelinopathy. Despite a large number of studies in this field, there is no effective method of gene therapy for these diseases yet. This work is intended to review main genetherapeutic methods in myodystrophy treatment, especially pre- and posttranscriptional genetic (biosynthetic) information modification, and analyze most optimal of them.

show abstract

Plasma Membrane Proteins: Dysferlin, Caveolin, PTRF/Cavin, Integrin α7, and Integrin α9

Cited by 2 publications

References 78 publications

Neuromuscular Pathology Case

Neuromuscular Pathology Case

Preand posttranscriptional genetic information modification in muscular dystrophy treatment

Contact Info

Product

Resources

About